A test method is provided for determining whether a person is a schizophrenic, which comprises suitably treating a plurality of test animals, obtaining a sample of the person's blood, pre-mixing the blood, or preferably the plasma therefrom with 3,4-dimethoxyphenylethylamine, internally administering the mixture to the test animals, and maintaining the animals under aggregated or crowded conditions while observing their behavior for amphetamine-like reaction and lethality as an indication of the...

A process and composition for ophthamological testing for patency in which there is direct observation of the rate and direction of flow of the composition toward and into the punctal orifices. The composition is a suspension of highly visible, minute particles in an isotonic liquid carrier, a drop of which is applied to the eyeball and the movement of the discrete particles observed under magnification at the meniscus formed at the margin of the eyelids.

A method is provided for rapidly screening candidates for precancerous atrophic H. gastritis by visualizing the presence of a hypoacidity condition of the gastric mucous membrane by applying droplets of an indicator to the stomach wall which indicator undergoes a marked color change in the presence of a hypoacidic condition and then detecting immediately the presence of that color change. The indicator employed is bromocresol green, bromophenol blue or bromochlorophenol blue.

Amyloid-targeting imaging agents such as radiolabeled amyloid targeting molecules and amyloid targeting molecule-chelator conjugates for imaging, e.g., amyloid plaques in vivo, and/or for the treatment of amyloidosis disorders. The invention provides amyloid-targeting imaging agents that are useful for imaging sites of amyloid disease. Imaging agents of the invention are capable of binding specifically to amyloid plaques, as an aid in diagnosis and/or early treatment of amyloidosis disorders.

To increase the chances of breeding an elite racehorse, a genetic dominance tree (GDT) of the prospective dam, and a GDT of the prospective sire, are constructed. A GDT has indicia for determining whether the horse has any dominant and substantially constant representative physical characteristic in the form of a combined body length (CBL) in its family. The prospective sire and dam are bred where there is such a dominant and relatively constant CBL common to both horses.

The present invention provides methods and systems for performing in-vivo flow cytometry to obtain desired information regarding one or more cell types of interest flowing through a subject's circulatory system. In one embodiment of the invention, a portion of the subject's circulating blood is illuminated with radiation having multiple wavelength components, and the backscattered radiation generated in response to the excitation radiation is detected at a plurality of scattering angles and anal...

A radiopharmaceutical for diagnostic imaging containing as an active ingredient a technetium-99m nitride heterocomplex comprising technetium-99m nitride and two different ligands coordinated therewith, i.e., a bisphosphinoamine compound as a .pi. electron acceptor and a bidentate ligand as a .pi. electron donor and represented by the following formula (I): [.sup.99mTc(N)(PNP)(XY)].sup.+ (I)wherein .sup.99mTc(N) is technetium-99m nitride, PNP is a bisphosphinoamine compound and XY is a bidentate ...

A method of optically detecting a tumor during surgery. The method includes imaging at least one test point defined on the tumor using a first optical imaging system to provide a first tumor image. The method further includes excising a first predetermined layer of the tumor for forming an in-vivo defect area. A predetermined contrast enhancing solution is disposed on the in-vivo defect area, which is adapted to interact with at least one cell anomaly, such as basal cell carcinoma, located on th...

The invention concerns the use of hemoglobin derivatives for determining plasma and/or blood volume, wherein the hemoglobin derivatives are stable chromoproteins with a molecular weight of at least 64 kDa. The use can encompass the treatment of a patient wherein (a) a defined quantity of hemoglobin derivative is applied to a patient, (b) the mixing of hemoglobin derivative with the blood of the patient is awaited, (b) at least one sample is taken from the patient, (c) the content of the hemoglob...

A process for the artificial insemination of female pigs, which comprises the step of introducing into the environment of the female pig immediately prior to testing for oestrus response at least one compound selected from 5.alpha.-androst-16-en-3-one and 3.alpha.-hydroxy-5.alpha.-androst-16-ene. In a preferred process the compound is administered in the form of a spray of liquid droplets bearing the steroid compound.